Export 26 results:
Filters: Author is Alloway,R. R.  [Clear All Filters]
Boardman RE, Alloway RR, Alexander JW, Buell JF, Cardi M, First MR, et al. African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression. Am J Transplant. 2005;5(2):356-65.
Trofe J, Buell JF, Beebe TM, Hanaway MJ, First MR, Alloway RR, et al. Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience. Am J Transplant. 2005;5(4 Pt 1):775-80.
Rogers CC, Alloway RR, Buell JF, Boardman R, Alexander JW, Cardi M, et al. Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression. Transplantation. 2005;80(1):26-33.
Buell JF, Gross T, Alloway RR, Trofe J, Woodle ES. Central nervous system tumors in donors: misdiagnosis carries a high morbidity and mortality. Transplant Proc. 2005;37(2):583-4.
Buell JF, Gross TG, Hanaway MJ, Trofe J, Muthiak C, First MR, et al. Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc. 2005;37(2):956-7.
Rogers CC, Hanaway M, Alloway RR, Alexander JW, Boardman RE, Trofe J, et al. Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy. Transplant Proc. 2005;37(2):795-7.
Buell JF, Papaconstantinou HT, Skalow B, Hanaway MJ, Alloway RR, Woodle ES. De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population. Transplant Proc. 2005;37(2):960-1.
Buell JF, Hanaway MJ, Thomas M, Munda R, Alloway RR, First MR, et al. Donor kidneys with small renal cell cancers: can they be transplanted? Transplant Proc. 2005;37(2):581-2.
Woodle ES, Alloway RR, Hanaway MJ, Buell JF, Thomas M, Roy-Chaudhury P, et al. Early corticosteroid withdrawal under modern immunosuppression in renal transplantation: multivariate analysis of risk factors for acute rejection. Transplant Proc. 2005;37(2):798-9.
Rogers CC, Alloway RR, Boardman R, Trofe J, Hanaway MJ, Alexander JW, et al. Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantation. Transplant Proc. 2005;37(2):812-3.
Woodle ES, Susskind B, Alloway RR, Hanaway MJ, Thomas M, Buell J, et al. Histocompatibility testing predicts acute rejection risk in early corticosteroid withdrawal regimens. Transplant Proc. 2005;37(2):809-11.
Woodle ES, Alloway RR, Buell JF, Alexander JW, Munda R, Roy-Chaudhury P, et al. Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppression. Am J Transplant. 2005;5(11):2740-4.
Hanaway MJ, Roy-Chaudhury P, Buell JF, Thomas M, Munda R, Alloway RR, et al. Pilot study of early corticosteroid elimination after pancreas transplantation. Transplant Proc. 2005;37(2):1287-8.
Alloway RR, Hanaway MJ, Trofe J, Boardman R, Rogers CC, Hanaway MJ, et al. A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience. Transplant Proc. 2005;37(2):802-3.
Buell JF, Hanaway MJ, Thomas M, Alloway RR, Woodle ES. Skin cancer following transplantation: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc. 2005;37(2):962-3.
Buell JF, Beebe TM, Gross TG, Trofe J, Hanaway MJ, Alloway RR, et al. United network for organ sharing publication on scientific registry of transplant recipients central nervous system donor cancer transmission data. Transplantation. 2005;79(5):623.